Moore Capital Management LP bought a new stake in shares of Ralliant Corporation (NYSE:RAL – Free Report) in the second quarter, Holdings Channel reports. The firm bought 687,038 shares of the company’s stock, valued at approximately $50,587,000. Ralliant makes up 0.8% of Moore Capital Management LP’s investment portfolio, making the stock its 21st largest holding.
Other institutional investors and hedge funds have also modified their holdings of the company. Danske Bank A S purchased a new stake in shares of Ralliant during the fourth quarter worth $25,000. Dunhill Financial LLC purchased a new position in Ralliant in the second quarter valued at about $25,000. Allworth Financial LP grew its stake in Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after purchasing an additional 293 shares in the last quarter. Palisade Asset Management LLC acquired a new position in Ralliant in the 3rd quarter worth about $26,000. Finally, BOKF NA acquired a new position in Ralliant in the 3rd quarter worth about $29,000.
Ralliant Trading Down 0.1%
Shares of RAL stock opened at $61.65 on Monday. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $75.41. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. The business’s 50 day moving average is $68.40 and its two-hundred day moving average is $56.53. The company has a market cap of $6.82 billion, a PE ratio of -5.68, a price-to-earnings-growth ratio of 2.29 and a beta of 1.61.
Ralliant Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s payout ratio is currently -1.84%.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on RAL. Evercore began coverage on Ralliant in a report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price target for the company. BMO Capital Markets assumed coverage on Ralliant in a report on Monday, July 20th. They issued a “market perform” rating and a $78.00 price objective on the stock. Vertical Research lowered shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price objective on the stock. in a research report on Wednesday, May 27th. Zacks Research raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Finally, Royal Bank Of Canada lifted their target price on shares of Ralliant from $71.00 to $73.00 and gave the company a “sector perform” rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $75.70.
Check Out Our Latest Research Report on Ralliant
Insider Transactions at Ralliant
In other news, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the transaction, the senior vice president directly owned 31,668 shares in the company, valued at approximately $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the completion of the transaction, the chief executive officer owned 251,967 shares in the company, valued at $18,088,710.93. The trade was a 4.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by corporate insiders.
Ralliant Company Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
See Also
- Five stocks we like better than Ralliant
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
